Filing Overview
Registrant: HF Enterprises Inc. (the request identifies Alset Inc.; the filing itself names HF Enterprises Inc.)
Form 8-K date: November 23, 2020, with the offering closing on November 27, 2020. The filing reports entry into a material underwriting agreement and related offering updates.
Material Financing Transaction
- The company agreed to sell 2,160,000 shares of common stock in its initial public offering at $7.00 per share.
- The offering generated approximately $12.7 million of net proceeds after underwriting discounts, fees, expenses, and other offering costs.
- Aegis Capital Corp. received a 60-day option to purchase up to an additional 324,000 shares at the offering price.
- The shares began trading on the Nasdaq Capital Market on November 24, 2020, under the symbol HFEN.
- At closing, the company issued Aegis a warrant to purchase 108,000 shares, equal to 5% of the shares sold in the offering.
- The representative’s warrant has an exercise price of $9.80 per share and is exercisable during the four-year period beginning on its issuance date.
Use of Proceeds and Financial Metrics
| Metric | Reported information |
|---|---|
| Gross offering proceeds | Approximately $15.1 million, based on 2,160,000 shares at $7.00 per share |
| Net offering proceeds | Approximately $12.7 million |
| Primary intended uses | Potential acquisitions of companies and properties, working capital, and general corporate purposes |
| Revenue, profit, margins, and operating cash flow | The filing text does not provide a clear value |
| Debt and liquidity | The filing does not provide a clear updated debt or liquidity balance |
Changes Versus Prior Comparable Period
This Form 8-K does not present comparative financial statements or operating results. The principal change disclosed is the company’s completion of its initial public offering, resulting in approximately $12.7 million of net proceeds, new public-market trading, and the issuance of the representative’s warrant.
Outlook, Risks, and Unusual Items
- Management expects to use the proceeds primarily for possible acquisitions and properties, as well as working capital and general corporate purposes. No specific acquisition, timing, or expected return is identified in the filing.
- The over-allotment option could result in the issuance of up to 324,000 additional shares, although the filing does not state whether the option was exercised.
- Exercise of the representative’s warrant could create additional dilution of existing stockholders.
- The filing includes customary representations and warranties in the underwriting agreement and states that investors should rely on the company’s other SEC disclosures for information about its current condition.
- No detailed discussion of operating risks, contingencies, guidance, or COVID-19 effects is included in the provided text.
Key Facts for Investors to Verify
- Whether the underwriters exercised any portion of the 324,000-share over-allotment option.
- The company’s post-offering cash balance, capitalization, debt, and fully diluted share count.
- The terms and potential dilution associated with the 108,000-share representative’s warrant.
- The specific acquisitions or property investments contemplated for the proceeds.
- The company’s subsequent financial performance and whether the stated acquisition and working-capital plans were implemented.
- The relationship between HF Enterprises Inc. in the filing and Alset Inc. identified in the request metadata.